Diligence memo · auto-generated · as of July 2, 2026
ReShape Lifesciences Inc.
ReShape Lifesciences Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
ReShape Lifesciences Inc. operates in Other Health Care, based in SAN CLEMENTE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
ReShape Lifesciences Inc. has raised $114M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $61M on 2017-10-02.
Most recent recorded round closed around 2018-07-10.
Valuation (modeled)modeled
Provath models ReShape Lifesciences Inc. at approximately $64M (range $10M–$168M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.06× the median modeled value of Series C Other Health Care companies in 2016–2018 (40 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 23 months.
Last raise 8.0 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.8× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 96% of Other Health Care peers (5377 compared).
Modeled value ranks above 71% of those peers.
Closest niche peers: Specialty Networks, LLC, New MMI Holdings, Inc., BioMatrix Holdings, L.L.C., Sea Hunter Holdings, LLC, Bind Benefits, Inc..
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.